![Jamal El-Mosleh](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jamal El-Mosleh
Chief Executive Officer at ELICERA THERAPEUTICS AB
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Magnus Essand | M | 60 | 10 years | |
Eva Agneta Edberg | F | 68 | 13 years | |
Nils Anders Haegerstrand | M | 63 | 6 years | |
Margareth Jorvid | F | 63 | 8 years | |
Di Yu | M | 39 | 10 years | |
Jens Nielsen | M | - |
Elypta AB
![]() Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | 7 years |
Christina Elisabeth Herder | M | 63 | 4 years | |
Jan Gustaf Zetterberg | M | 73 | 4 years | |
Francesco Gatto | M | - |
Elypta AB
![]() Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | 7 years |
Pontus Ottosson | M | 49 |
Elypta AB
![]() Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | 7 years |
Anders Olof Adolf Ekblom | M | 70 |
Elypta AB
![]() Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | 6 years |
Jonas Jendi | M | 54 |
Elypta AB
![]() Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | 4 years |
Anna Koptina Gültekin | M | - | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Per-Olof Bertil Gunnesson | M | 79 | 6 years | |
Carlos de Sousa | M | 66 | 3 years | |
Sven Arne Andréasson | M | 72 | 3 years | |
Carl Henrik Palm | M | 66 | 4 years | |
Gunnar Magnus Modee Persson | M | 64 | 5 years | |
Bengt Daniel Furberg | M | 83 | 8 years | |
Annette Colin Lövgren | F | 59 | 1 years | |
Lars Martin Lindström | M | 44 | 10 years | |
Karin Hoogendoorn | M | 54 | - | |
Rolf Ingvar Lenart | M | 68 | - | |
Magnus Nilsson | M | 68 | 5 years | |
Henrik Elofsson | M | 42 | - | |
Lena Margareta Torlegård | F | 61 | - | |
Lise-Lotte Hallbäck | F | 58 | 3 years | |
Peter Suenaert | M | 56 | - |
Statistics
Country | Connections | % of total |
---|---|---|
Sweden | 28 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jamal El-Mosleh
- Personal Network